조영증강 유방촬영술 시장 규모는 2023년 23억 달러, 2024년 24억 4,000만 달러에서 2032년에는 38억 9,000만 달러로 확대될 것으로 예상되며, 예측 기간(2025-2032년) 동안 6.0%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.
조영증강 유방촬영술(CEM)은 듀얼 에너지 기술을 활용하여 디지털 유방촬영술과 정맥 조영술의 장점을 효과적으로 결합하여 진단 시나리오에서 전장 디지털 유방촬영술(FFDM) 및 초음파에 비해 유방암 검출에 있어 더 나은 민감도를 보여줍니다. 노화, 비만, 가족력 등의 위험 요인에 의해 악화되는 유방암의 전 세계 유병률 증가를 고려할 때, CEM의 인기는 급상승하여 현재 주요 영상 진단 기술로 자리 잡았습니다. 주로 여성에게 발생하는 유방암의 대부분이 여성에게 발생하기 때문에 큰 시장 수요가 두드러집니다. 유방의 덩어리, 크기와 모양의 변화, 분비물 등의 증상은 효과적인 검출 솔루션의 시급성을 강조하고 있습니다. 그 결과, 유방암 발병률 증가는 첨단 영상 기술 시장 성장을 지속적으로 촉진하고 있습니다.
Contrast Enhanced Mammography Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.44 billion in 2024 to USD 3.89 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).
By leveraging a dual-energy technique, Contrast-Enhanced Mammography (CEM) effectively merges the advantages of digital mammography with intravenous contrast, showcasing superior sensitivity in breast cancer detection compared to Full-Field Digital Mammography (FFDM) and ultrasound in diagnostic scenarios. Given the escalating global prevalence of breast cancer-exacerbated by risk factors such as age, obesity, and a family history of the disease-CEM has surged in popularity and is now a leading imaging technique. The majority of breast cancer cases, primarily affecting females, highlight significant market demand. Symptoms like breast lumps, changes in size and shape, and fluid discharge underscore the urgency for effective detection solutions. Consequently, the increasing incidence of breast cancer continues to propel market growth for advanced imaging technologies.
Top-down and bottom-up approaches were used to estimate and validate the size of the Contrast Enhanced Mammography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Contrast Enhanced Mammography Market Segments Analysis
Global Contrast Enhanced Mammography Market is segmented by Applications, End User and region. Based on Applications, the market is segmented into Screening and Diagnosis. Based on End User, the market is segmented into Hospital, Diagnostic Centres, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Contrast Enhanced Mammography Market
The Contrast Enhanced Mammography market is primarily driven by the increasing prevalence of breast cancer, which stands as the most frequently diagnosed cancer among women globally. Early detection of breast cancer significantly enhances treatment efficacy, allowing for improved patient outcomes. Typically, treatment regimens for breast cancer patients encompass a combination of surgery, radiation therapy, and various medications, including hormone therapy, chemotherapy, and targeted biological therapies. These interventions are crucial in managing the disease, as they not only halt the progression of cancer but also reduce the risk of metastasis, ultimately contributing to higher survival rates and better quality of life for affected individuals.
Restraints in the Contrast Enhanced Mammography Market
The Contrast Enhanced Mammography market faces several significant barriers that could hinder its growth and adoption. Firstly, being a relatively novel technology, the costs associated with the equipment, materials, and necessary training are considerably higher than those for traditional mammography, posing a financial challenge for healthcare providers. Additionally, the limited availability of facilities offering this advanced imaging technique makes it difficult for patients, especially in rural or remote regions, to access these services. Furthermore, obtaining regulatory approval for clinical use is often a lengthy and costly process, potentially delaying market entry. Lastly, despite the encouraging results from clinical studies, the absence of long-term data on the technology's safety and effectiveness may lead some healthcare professionals to exercise caution in embracing this advancement until more substantial evidence is presented.
Market Trends of the Contrast Enhanced Mammography Market
The Contrast Enhanced Mammography (CEM) market is experiencing robust growth, driven by the increasing incidence of breast cancer among women and the demand for advanced diagnostic techniques. As healthcare providers adopt state-of-the-art technologies for early detection, CEM stands out for its superior sensitivity and specificity compared to traditional methods. This trend is fueled by the desire for more accurate and timely results, enabling better treatment decisions. Enhanced imaging technologies not only improve diagnostic performance but also instill greater confidence among patients and healthcare professionals, ultimately propelling market expansion and innovation in breast cancer management solutions.